AMBER TURPIN: Open Payments
NPI 1912579368 · LOWELL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,034 in 44 payments from 12 companies in 2025. Trend: 2023 $856 · 2024 $1,373 · 2025 $1,034
Food & beverage: $1,034
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $497 |
| Amgen Inc. | 16 | $212 |
| Otsuka America Pharmaceutical, Inc. | 4 | $82 |
| Novo Nordisk Inc | 3 | $60 |
| ABBVIE INC. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| PFIZER INC. | 1 | $25 |
| Lucid Diagnostics Inc. | 1 | $22 |
| Phadia US Inc. | 1 | $18 |
| Antares Pharma, Inc. | 1 | $15 |
Products named: FARXIGA, OTEZLA, AIRSUPRA, REXULTI, BREZTRI, TRINTELLIX, REPATHA, NURTEC ODT.
Industry payments across IN — which companies pay providers there.
